About Standard Molecular
Standard Molecular is a company based in Cambridge (United States) founded in 2014 by Chesley Leslin, Nathaniel Weiss, and David Artz. It operates as a B2B. Standard Molecular has raised $1.44 million across 1 funding round. Standard Molecular operates in a competitive market with competitors including DNAnexus, Helix, Benchling, Cytel and Genuity Science, among others.
- Headquarter Cambridge, United States
- Founders Chesley Leslin, Nathaniel Weiss, David Artz
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Standard Molecular, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.44 M (USD)
in 1 rounds
-
Latest Funding Round
$1.44 M (USD), Seed
Apr 09, 2018
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Standard Molecular
Standard Molecular has successfully raised a total of $1.44M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.44 million completed in April 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by Standard Molecular
Investment portfolio details for Standard Molecular
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Standard Molecular
Detailed financials for Standard Molecular
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Standard Molecular Comparisons
Peer comparison for Standard Molecular
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Standard Molecular
Standard Molecular operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DNAnexus, Helix, Benchling, Cytel and Genuity Science, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cloud-based genome informatics and data management are provided.
|
|
| Locked | Locked | Locked |
Genomic database for clinical research is provided.
|
|
| Locked | Locked | Locked |
Cloud-based bioinformatics platform is offered for biotech research.
|
|
| Locked | Locked | Locked |
Data analysis and statistical solutions are provided for life sciences.
|
|
| Locked | Locked | Locked |
AI-based omics data analysis solutions are provided to researchers.
|
|
| Locked | Locked | Locked |
Developer of predictive informatics based platform for drug discovery
|
Detailed competitors of Standard Molecular
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Standard Molecular
Complete news archive for Standard Molecular
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Standard Molecular
Standard Molecular was founded in 2014 and raised its 1st funding round 4 years after it was founded.
Standard Molecular is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Nathaniel Weiss is the current CEO of Standard Molecular. They have also founded this company.
Standard Molecular is a funded company, having raised a total of $1.44M across 1 funding round to date.
Standard Molecular, led by Chesley Leslin as Co-Founder, Nathaniel Weiss as ex-Founder, CEO, David Artz as Co-Founder, specializes in providing healthcare solutions, advancing biotech innovations, focusing on genomic solutions, and diagnostic systems. Standard Molecular provides genomic information systems for diagnostic and therapeutic applications. The team drives innovation, quality service, and sustainable practices to achieve excellence and client satisfaction.